Driveline Infections Associated With Durable Left Ventricular Assist Device Support: An Ounce of Prevention is Worth a Pound of Cure

Affiliations

Comment

Francis D Pagani. ASAIO J. 2022.

. 2022 Dec 1;68(12):1459-1460.

doi: 10.1097/MAT.0000000000001857. Epub 2022 Nov 21.

¹ From the Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI.

No abstract available

Comment on

Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy.
Lumish HS, Cagliostro B, Braghieri L, Bohn B, Mondellini GM, Antler K, Feldman V, Kleet A, Murphy J, Tiburcio M, Fidlow K, Jennings D, Sayer GT, Takeda K, Naka Y, Demmer RT, Aaron JG, Uriel N, Colombo PC, Yuzefpolskaya M. Lumish HS, et al. ASAIO J. 2022 Dec 1;68(12):1450-1458. doi: 10.1097/MAT.0000000000001690. Epub 2022 Feb 27. ASAIO J. 2022. PMID: 35239537 Free PMC article.

1. Miller LW: Left ventricular assist devices are underutilized. Circulation. 123: 1552–1558, 2011.
1. Vidula H, Takeda K, Estep JD, et al.: Hospitalization patterns and impact of a magnetically-levitated left ventricular assist device in the MOMENTUM 3 Trial. JACC Heart Fail. 10: 470–481, 2022.
1. Mehra MR, Uriel N, Naka Y, et al.: A fully magnetically levitated left ventricular assist device - final report. N Engl J Med. 25: 1618–1627, 2019.
1. Patel CB, Blue L, Cagliostro B, et al.: Left ventricular assist systems and infection-related outcomes: a comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 39: 774–781, 2020.
1. Zhou S, Yang G, Zhang M, et al.: Mortality following durable left ventricular assist device implantation by timing and type of first infection. J Thorac Cardiovasc Surg. 9: S0022–5223(21)01532-4, 2021.